SCHEMBL295486 — predicted protein targets

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	TACR3	P29371	5/20	0.77

▸	TACR1	P25103	4/20	0.77

▸	TACR2	P21452	3/20	0.77

▸	KCNH2	Q12809	6/20	0.39

▸	GPR119	Q8TDV5	4/20	0.39

▸	UBE2M	P61081	2/20	0.38

▸	DCUN1D1	Q96GG9	2/20	0.38

▸	F10	P00742	2/20	0.35

▸	CYP3A4	P08684	2/20	0.35

▸	SLC6A9	P48067	2/20	0.35

▸	CYP2D6	P10635	1/20	0.35

▸	CCR5	P51681	1/20	0.35

▸	MEN1	O00255	1/20	0.35

▸	ALDH1A1	P00352	1/20	0.35

▸	MAPT	P10636	1/20	0.35

▸	KMT2A	Q03164	1/20	0.35

▸	NPSR1	Q6W5P4	1/20	0.35

▸	RORC	P51449	1/20	0.35

▸	TRPM8	Q7Z2W7	1/20	0.34

▸	SLC6A5	Q9Y345	1/20	0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL3279794	0.99	TACR3 (0.75)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL296726	0.95	TACR3 (0.69)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL296240	0.94	TACR3 (0.68)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL295923	0.92	TACR3 (0.81)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL295664	0.92	TACR3 (0.63)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL3271088	0.91	TACR3 (0.80)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL295073	0.91	TACR3 (0.80)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL296465	0.91	TACR3 (0.63)	TACR3TACR1TACR2KCNH2GPR119
SCHEMBL295335	0.90	TACR3 (0.61)	TACR3TACR1TACR2KCNH2UBE2M
SCHEMBL296789	0.88	TACR3 (0.59)	TACR3TACR1TACR2UBE2MDCUN1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-2200982-B1	PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS	HOFFMANN LA ROCHE (CH)	2012-03-14	—	—	EP	claimed
US-20110021565-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	KNUST HENNER	2011-01-27	—	—	US	claimed
US-20090076081-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	HOFFMANN-LA ROCHE, INC.	2009-03-19	—	—	US	claimed
EP-2200982-B1	PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS	HOFFMANN LA ROCHE (CH)	2012-03-14	—	—	EP	disclosed
US-20110021565-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	KNUST HENNER	2011-01-27	—	—	US	disclosed
US-20110021565-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	KNUST HENNER	2011-01-27	—	—	US	disclosed
US-20110021565-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	KNUST HENNER	2011-01-27	—	—	US	disclosed
US-20090076081-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	HOFFMANN-LA ROCHE, INC.	2009-03-19	—	—	US	disclosed
US-20090076081-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	HOFFMANN-LA ROCHE, INC.	2009-03-19	—	—	US	disclosed
US-20090076081-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	HOFFMANN-LA ROCHE, INC.	2009-03-19	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20090076081-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	DRD2, DRD3, OPRL1	TACR3 95/4885TACR1 26/4885TACR2 21/4885
US-20110021565-A1	PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS	DRD2, DRD3, OPRL1	TACR3 95/4885TACR1 26/4885TACR2 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.